Colon Cancer : Good news, new drug improves survival rates

Genentech Inc’s new drug Avastin, when combined with chemotherapy has improved survival rates in Colon Cancer patients with advanced disease. Avastin is in a new class of anti – cancer drugs, angiogessis inhibitors. [P] We expect to have further information in the near future. Keep checking for updates.

Webmaster

June 30, 2003